AXE - Archer Materials

barney said:

Lol .. I have no idea of what you speak Rock ...... Obviously I am way ahead of my time

Click to expand...

Nice when a plan comes together Rocketman

My projected Levels 1 2 and 3 all accommodated for in pretty quick succession ... particularly today's little rip and carve.

Hope she keeps on doing the business for you @frugal.rock

The other day chart:



Todays action:

ASX Announcement (ASX: AXE)
25 March 2024

Archer and EPFL co-develop a single chip integrated pulsed
electron spin resonance microsystem

Highlights

• Archer Materials and research partner EPFL have developed a pulsed electron spin resonance chip, advancing Archer’s 12CQ quantum technology project.

• The new chip detects and analyses materials for important signs of quantum electron spin manipulation at a very small scale.

• The chip’s features open potential opportunities for Archer to develop quantum sensors, miniaturised spectrometers, and analytical devices for precision sensing.

• The chip is smaller than 1 mm in size and is manufactured using a 130 nm SiGe BiCMOS technology.

• Archer is continuing to work with EPFL to build capability in radiofrequency devices and circuit design for potential applications in quantum technology.

• The technical details of the new chip will be made publicly available this week.

Explains quite a bit in this.

@debtfree

Some options expired ...
May update

ASX Announcement (ASX: AXE)
17 June 2024

Archer Biochip gFET design fabricated on a six-inch wafer by foundry partner in Spain

Highlights

• Archer Materials has advanced its Biochip gFET design fabrication testing through its foundry partner in Spain, Graphenea.

• Graphenea fabricated an Archer Biochip gFET design through a six-inch whole wafer run, producing 145 chips with 8 gFET devices on each chip.

• The fabrication is the first six-inch wafer run for Archer, representing an intermediary wafer size test run between the typical four-inch R&D test bed wafers and commercial-scale eight- and twelve-inch wafers.

• The gFET designs include advances over previous chip features to address technology challenges in maintaining device stability required for potential sensing applications.

• Archer continues to work with several foundries in Europe to develop its Biochip gFETs, with a miniaturised chip design undergoing whole-wafer fabrication in parallel and is expected to be completed in a few weeks.

now at 12 month low of 29c

...given the axe or fell on his sword?

management and leadership changes following last Friday’s announcement of the resignation of CEO Dr Mohammad Choucair.

Appointment of Chief Technology Officer
Dr Simon Ruffell has been promoted to Chief Technology Officer to ensure a smooth transition and the continued growth of the Company’s two key projects. Dr Ruffell is well qualified for the role of CTO. He has a PhD in Physics from the University of Western Ontario and a Masters of Electronic and Electrical Engineering (first class) from the University of Surrey, UK.

Simon joined Archer in February 2024 as Engineering Manager, responsible for managing and progressing both the quantum and biosensor teams and projects. Over this time Simon has taken on the leadership of the development streams for these projects, and is well placed to continue to lead these activities going forward.

Simon has 20 years of international experience working on technology projects and managing multi-functional teams, including hardware, process and software engineering teams. Before joining Archer, Simon was a Principal Hardware Engineering Manager at Microsoft, a Senior Manager at Applied Materials and Semiconductor, and Quantum Engagement Manager at the University of Sydney.

Strong leadership to drive Archer’s progress
Greg English will remain as Executive Chairman and will work closely with Simon Ruffell to ensure the continued development of Archer’s quantum and biochip projects. In addition, Archer’s broader leadership team and advisory board, which has deep semiconductor industry experience gained across companies like Intel, Silanna, Altium, and CSIRO, is well placed to ensure the Company continues on its path to create transformational technology solutions to complex global challenges.

Archer’s Executive Chairman, Greg English, said,
“Archer is fortunate to be in a position where its leaders have deep experience across the semiconductor and quantum sectors, with leading global technology organisations. I have complete faith in Simon and the wider Archer team to advance the very exciting development pathways of the 12CQ qubit and the Biochip technologies."

Some success at last? Up 11%

Archer Materials has successfully miniaturised its Biochip graphene field effect transistor (gFET) design, reducing the size of the chip by 97%. This advancement, fabricated by Archer’s foundry partner Applied Nanolayers in the Netherlands, makes the gFET more cost-effective to produce while improving its foundry readiness. The miniaturised chips have already undergone wafer dicing and assembly at AOI Electronics in Japan and are now being tested by Archer.

This new design is a key step towards Archer’s goal of using the Biochip for at-home testing of chronic kidney disease, with the miniaturised gFET sensors playing a crucial role in the functionality. The company aims to reduce fabrication costs and increase the production scale, with over a thousand chips expected to be produced in future wafer runs. This progress also strengthens Archer’s partnerships with semiconductor supply-chain partners and moves the Biochip closer to commercialisation.

Some chuts

38.5c


1. The Company is not aware of any information concerning it that has not been announced which, if known, may explain the recent trading pattern in the securities of Archer Materials Limited.

2. Not applicable.

3. The Company is not aware of any specific explanation related to the Company for the recent price increase and increase in volume of shares traded. However, as a possible explanation for the recent trading activity, the Company acknowledges the recent announcement on 9 December 2024, from Alphabet (Google’s parent entity) in which it unveiled a new generation chip that helped overcome a key challenge in quantum computing. Off the back of this, there was increased investor interest, with US quantum computing stocks and quantum ETFs trading up materially. Archer Materials is the only known quantum computing technology company on the ASX.

4. Archer Materials Limited confirms that it is in compliance with the ASX listing rules and, in particular, with listing rule 3.1.

Haven't held for a while now, but it appears it might be back in favour based on above?
And this supports my theory...

I saw this and wondered where to put it:

No real thesis and I'm not a holder at the time of writing. It's the only Quantum play on the ASX for now. Their Biochip, 12CQ and underlying materials technology portfolio gives a few shots at success. This will be one rollercoaster ride I expect.

I could not Find another AXE thread ---Probably BLOCKED I guess
I have entered the AXE in the 2025 Regatta
Here's Hoping she Holds at 0.40c

kenny said:

. It's the only Quantum play on the ASX for now. Their Biochip, 12CQ and underlying materials technology portfolio gives a few shots at success. This will be one rollercoaster ride I expect.

Click to expand...

should there be a broad thread for

The US market has a bunch of stocks, and these have had a ride, recently

.
nothing to see here.
.

The Quantum Hype Machine​

By Ed D'Agostino | January 17, 2025

Everybody has an opinion about quantum computing lately. Last week Nvidia CEO Jensen Huang suggested we were 15–30 years away from “useful” quantum computing. Mark Zuckerberg joined the chorus, telling Joe Rogan that useful quantum was still “quite a ways off.”

Shares of small quantum computing companies like D-Wave Quantum, Inc. (QBTS), Rigetti Computing, Inc. (RGTI), IonQ Inc. (IONQ), and Quantum Computing Inc. (QUBT) all plunged after Jensen’s negative comments. But they’ve been recovering quickly.

These stocks had been on a tear for the past few months, prior to Huang’s comments. They were riding a massive turnaround in sentiment from early 2024. As recently as October, both Rigetti and D-Wave were at risk of being delisted (for the second and third times, respectively).

The catalyst for quantum computing stocks was Google announcing that its newest quantum chip, Willow, had completed a computation that would take a classical computer 10 septillion years… in 5 minutes.

Rigetti’s CEO, Subodh Kulkarni, shared a refreshingly hype-free outlook on the state of quantum in a recent interview. Kulkarni said that Rigetti is making quantum processing units, available for sale, today. But, he cautioned, their error rates are still too high for broad adoption. Today it is mainly government agencies that are issuing contracts for his QPUs. He estimates we are 3–5 years away from true quantum advantage, when quantum computing will start to make a material difference.

When that happens, he predicts we’ll see quantum computing applied to high-variable problems such as weather forecasting and pharmaceutical development. It could also be used for breaking encryption, which poses serious issues for businesses and governments. But again, quantum will also help solve for that.

more at